RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > In Focus: Postmarketing Compliance Activities

In Focus: Postmarketing Compliance Activities

Posted 01 September 2009 | By

It is well known that postmarket activities are the most resource-intensive phase of a pharmaceutical or medical device product's lifecycle. This phase includes not only marketing and pharmacovigilance/vigilance activities, but also the upkeep and maintenance of the license. License maintenance activities include applying for variations and following up on specific obligations and measures. Companies need to exercise strict control over their change management systems to avoid compliance issues.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.